NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
02/08/2025
Back to search
Official data from USPTO
SEQUOIA VACCINES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
SEQUOIA VACCINES
ST13
US500000087215450Class
42
Filing
87215450
Registration
5576443
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
02/09/2025
Trademark type
Word
Nice classes
42
Filing date
10/25/2016
Registration date
10/02/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/08/2025
Last transaction
02/09/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2016-10-00
First use in commerce
2016-10-00
Drawing code
4
Owner type
03
Owner location
Saint Louis, MO
Examiner
GOLD, BARBARA
Current location
Historical data usage
Holders and representatives
Holders
Sequoia Sciences, Inc.
Representatives
Tawnya Wojciechowski TRW LAW GROUP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Biological research; Laboratory research in the field of vaccine and pharamceutical development; Laboratory research services relating to pharmaceuticals; Chemicalbiochemicalbiological and bacteriological research and analysis; Conducting clinical trials for others in the field of vaccine and pharmaceutical development; Consulting services in the fields of biotechnologypharmaceutical research and developmentlaboratory testingdiagnosticspharmacogenetics; Development and establishment of testing specifications and procedures in the field of vaccine and pharmaceutical development; Research and development of vaccines and medicines; Researchdevelopmentengineering and testing services in the fields of immunopharmaceuticals and vaccines; Researchdevelopmentengineering and testing services in the fields of immunopharmaceuticals and vaccines
Publications
History of USPTO decisions and trademark events.
38 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
02/08/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/08/2025
E815
TEAS SECTION 8 & 15 RECEIVED
09/26/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
10/02/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
10/02/2018
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
08/28/2018
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
08/26/2018
SUPC
STATEMENT OF USE PROCESSING COMPLETE
08/24/2018
IUAF
USE AMENDMENT FILED
08/22/2018
EISU
TEAS STATEMENT OF USE RECEIVED
08/22/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/15/2018
EX2G
SOU EXTENSION 2 GRANTED
08/14/2018
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
08/14/2018
NREV
NOTICE OF REVIVAL - E-MAILED
07/10/2018
TPEX
SOU EXTENSION RECEIVED WITH TEAS PETITION
07/09/2018
PETG
PETITION TO REVIVE-GRANTED
07/09/2018
PROA
TEAS PETITION TO REVIVE RECEIVED
07/09/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/09/2018
MAB6
ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
06/18/2018
ABN6
ABANDONMENT - NO USE STATEMENT FILED
06/18/2018
EXT2
SOU EXTENSION 2 FILED
05/16/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/18/2017
EX1G
SOU EXTENSION 1 GRANTED
11/16/2017
EXT1
SOU EXTENSION 1 FILED
11/16/2017
EEXT
SOU TEAS EXTENSION RECEIVED
11/16/2017
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05/16/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/21/2017
PUBO
PUBLISHED FOR OPPOSITION
03/21/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/01/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/08/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
02/08/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/08/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
02/08/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/08/2017
DOCK
ASSIGNED TO EXAMINER
02/02/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/31/2016
NWAP
NEW APPLICATION ENTERED
10/28/2016
Continuous trademark protection
Get notified about every new filing that threatens SEQUOIA VACCINES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.